Key result
Multifunctional lipid nanoparticles enable SPECT/MRI plaque visualization and induce favorable M1-to-M2 macrophage polarization.
Why the study?
Curcumin can polarize macrophages to promote atherosclerotic plaque stability but lacks specific targeting to inflammatory macrophages.
Does targeted delivery of curcumin using 9-CCN-(125I-ION/Cur)-LNPs improve imaging and stabilize vulnerable atherosclerotic plaques in animal models?
Does targeted delivery of curcumin using 9-CCN-(125I-ION/Cur)-LNPs improve imaging and stabilize vulnerable atherosclerotic plaques in animal models?
A novel theranostic nanoparticle containing curcumin enables multimodal imaging and promotes stabilization of vulnerable atherosclerotic plaques via macrophage polarization in preclinical models.
May advance multimodal plaque imaging and stabilization strategies; leaves open clinical translation from this animal model.
BACKGROUND Curcumin has emerged as a promising candidate capable of polarization of macrophages, which promote the stability of atherosclerotic plaque. Nevertheless, a notable limitation lies in the non-specific nature of curcumin’s targeting. The present study endeavors to harness multifunctional lipid nanoparticles (MLNPs), which could both facilitate imaging and achieve targeted delivery of curcumin specifically to inflammatory macrophages, to effectively counteract vulnerable plaque and mitigate the risk of ischemic events. METHODS The term “MLNPs”, for targeted delivery of curcumin using multimodal imaging techniques including single photon emission computed tomography (SPECT) and magnetic resonance imaging (MRI), refers to a new type of nanoparticle designed to specifically target and modulate macrophages with phagocytic function. These nanoparticles are cholesteryl-9-carboxynonanoate-( 125 I-iron oxide nanoparticle/Cur)-lipid-coated nanoparticles [9-CCN-( 125 I-ION/Cur)-LNPs], which carry hybrid imaging agents. These agents are combinations of 125I-ION and lipids that contain phagocytic “eat-me” signals, which induces macrophages to swallow MLNPs. RESULTS The accumulation of the devised 9-CCN-( 125 I-ION/Cur)-LNPs on the unstable plaque of animal models in vivo was accurately reflected and lesions were highlighted by both SPECT and MRI. The intense radioactive signals on SPECT images facilitated the identification and quantification of the target lesion, while MRI based on ION particles facilitated the visualization of the focal localization and volumetry of atherosclerotic plaque. The targeted distribution of the unstable plaque in the rabbit aorta was further confirmed by ex vivo planar images of nuclide and Prussian blue staining for ION. Additionally, 9-CCN-( 125 I-ION/Cur)-LNPs were found to specifically and effectively bind to the pro-inflammatory M1 macrophages present in the unstable plaque, resulting in the accumulation of radionuclide and hypointensity on T2W images. CONCLUSIONS The 9-CCN-( 125 I-ION/Cur)-LNPs demonstrated remarkable capability in the delivery of both 125 I-ION and curcumin to macrophages, ultimately resulting in M1-M2 macrophage polarization, which may offer valuable insights into addressing unstable atherosclerotic plaque.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2023) studied Atherosclerosis. 9-CCN-(125I-ION/Cur)-LNPs vs. 9-CCN(125I-ION)-LNPS (without curcumin) was evaluated on Macrophage polarization (M1 to M2) and plaque visualization. 9-CCN-(125I-ION/Cur)-LNPs successfully delivered curcumin to macrophages, enabling SPECT/MRI visualization of atherosclerotic plaques and inducing M1-to-M2 macrophage polarization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: